In a woman with cT2 cN+ ER-negative HER2-positive breast cancer with a solitary lung metastasis and clinical complete response to first-line systemic therapy, 68% of experts recommended surgery of the primary tumor with adjuvant radiotherapy, while 14% recommended neither surgery nor radiotherapy. The gene discussed is ERBB2; the disease is breast carcinoma.